SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-21-005342
Filing Date
2021-08-11
Accepted
2021-08-11 16:17:40
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT vnrx_10q.htm   iXBRL 10-Q 1024475
2 EXHIBIT 31.1 SECTION 302 CERTIFICATION vnrx_ex311.htm EX-31.1 9608
3 EXHIBIT 31.2 SECTION 302 CERTIFICATION vnrx_ex312.htm EX-31.2 9443
4 EXHIBIT 32.1 SECTION 906 CERTIFICATION vnrx_ex321.htm EX-32.1 5483
  Complete submission text file 0001477932-21-005342.txt   5181152

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20210630.xsd EX-101.SCH 63554
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20210630_lab.xml EX-101.LAB 352270
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20210630_cal.xml EX-101.CAL 45527
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20210630_pre.xml EX-101.PRE 292782
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20210630_def.xml EX-101.DEF 192199
10 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_10q_htm.xml XML 831162
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36833 | Film No.: 211163652
SIC: 2835 In Vitro & In Vivo Diagnostic Substances